medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2010, Number 03

<< Back Next >>

Ginecol Obstet Mex 2010; 78 (03)

Estrogen therapy in menopause. Clinical study in evolution (KEEPS) to explain the risk-benefit dispute to administration

Zárate A, Hernández-Valencia M

Language: Spanish
References: 8
Page: 191-194
PDF size: 364.49 Kb.


ABSTRACT

The Kronos Early Estrogen Prevention Study (KEEPS) is a randomized clinical and controlled study, with the objective of clarifying the controversy that arisen previous studies about the risk-benefit factor with use of estrogens in postmenopausal women. Healthy women aged 42-58 years who are within 36 months of their last menstrual period have been recruited to receive either oral estrogens or patches of estradiol; in addition both groups are given oral micronized progesterone for 11 days of each month. Outcomes will be carotid intimae medial thickness and the accrual of coronary calcium; collaterally subrogate outcomes will be lipoproteins concentrations, coagulation markers, bone densitometry, mammography, skin characteristics and cognitive evaluation.
The hypothesis consists in the presence of a window of therapeutic opportunity for the use of estrogens in low dose in healthy women with recent menopause.


REFERENCES

  1. Manson JE, Bassuk SS, Harman SM, et al. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause 2006;13:139-147.

  2. Colditz GA, Willet WC, Hunter DJ, et al. Family history, age and risk of breast cancer. Prospective data from the Nurses’ Health Study. JAMA 1993;270:338-343.

  3. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogens plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321-333.

  4. HERS research group. Cardiovascular disease outcomes during 6-8 years of hormone therapy. Heart and estrogens/progestin replacement study follow-up (HERS II). JAMA 2002;288:49-57.

  5. Bath PMW, Gray LJ. Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 2005;330:342-344.

  6. Ettinger B, Barret-Connor E, Hop LA, et al. When is it appropriate to prescribe postmenopausal hormone therapy? Menopause 2006;13:404-410.

  7. Zárate A, Saucedo R, Basurto L, Martínez C. La enfermedad cardiovascular como amenaza actual para la mujer adulta mayor. La relación con los estrógenos. Ginecol Obstet Mex 2007;75:286-292.

  8. Zárate A, Hernández VA, Basurto L. Estado actual del tratamiento hormonal en la menopausia. Rev Fac Med UNAM 2005;48:14-19.




2020     |     www.medigraphic.com